25 0 0
Fundamentally a STRONG company and it had recent news for its upmove

Dr             Reddy's Laboratories has expanded strategic collaboration with Amgen             , one of the world's leading independent biotechnology companies, to market and distribute three of Amgen's medicines             in India in the therapy areas of oncology and osteoporosis. Under the terms of the collaboration, the company will commercialise XGEVA'(denosumab), Vectibix' (panitumumab) and Prolia (donosumab) in India.

The BSE             group 'A' stock of face value Rs             . 5 has touched a 52 week high of Rs             . 4382.95 on 20-Oct-2015 and a 52 week low of Rs             . 2750.00 on 21-Jan-2016.

The promoters holding in the company stood at 26.37%, while institutions and non-institutions held 41.16% and 15.64% respectively.

Dr             . Reddy’s Laboratories has been listed as an Index component of the Dow Jones Sustainability Indices (DJSI) 2016 in the Pharmaceuticals, Biotechnology & Life Sciences Industry Group. The pharma             major has been recognized for its corporate sustainability leadership and is the only pharmaceutical company on the Index of Emerging Markets.
The listing was based on 22 criterion, with Dr             . Reddy’s receiving high scores for Product Quality and Recall Management, Codes of Business Conduct, Environmental Reporting, Corporate Citizenship and Philanthropy.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out